Filter by content type
Filter by year
Poster: The Fifth International Cancer lmmunotherapy Conference in Paris, France Interim results from pepinemab in combination with avelumab in NSCLC patients who progressed on prior anti-PDx therapy (CLASSICAL – Lung)
Vaccinex Announces $3 Million Award from the Alzheimer’s Drug Discovery Foundation
December 10, 2019 - … and our collaboration with Merck KGaA in Non-Small Cell Lung Cancer could bring important benefits to our patients … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … and our collaboration with Merck KGaA in Non-Small Cell Lung Cancer could bring important benefits to our patients …
Vaccinex, Inc. Presented Previously Disclosed Data from Ongoing Phase 1/2 Trial of VX15/2503 (Pepinemab) in Huntington’s Disease (the “SIGNAL Trial”) at Cambridge Healthtech Institute’s 18th Annual PepTalk
January 17, 2019 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based …
Invited Podium Presentation: The Fifth International Cancer lmmunotherapy Conference in Paris, France Interim results from pepinemab in combination with avelumab in NSCLC patients who progressed on prior anti-PDx therapy (CLASSICAL – Lung)
Vaccinex, Inc. Announces Completion of Enrollment for Its “SIGNAL” Huntington’s Disease Trial
January 16, 2019 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in …
Vaccinex Announces $13.8 Million Private Placement
July 31, 2019 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in …
Vaccinex Details Scientific Rationale for Expanding Pepinemab Clinical Programs to Include Alzheimer’s Disease
December 9, 2019 - … with currently active clinical trials in non-small cell lung cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in non-small cell lung cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in non-small cell lung cancer and Huntington’s disease. Vaccinex is based in …
Pagination
- Previous page
- Page 3